Inmolecule Nanotech (XPAR:MLINA) Research & Development: € Mil (TTM As of Dec. 2024)


XPAR:MLINA Inmolecule Nanotech SA XPAR:MLINA
6 GF Score
Price €4.08
! 2 Warning Signs
View Full Analysis

What is Inmolecule Nanotech Research & Development?

Inmolecule Nanotech XPAR:MLINA 6 Research & Development is € Mil as of Dec. 2024. GuruFocus rates XPAR:MLINA with a GF Score™ of 6/100. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Inmolecule Nanotech's Research & Development for the six months ended in Dec. 2024 was €0.00 Mil. Inmolecule Nanotech does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in Dec. 2024.

Inmolecule Nanotech  (XPAR:MLINA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Inmolecule Nanotech Research & Development Related Terms

Inmolecule Nanotech Research & Development Historical Data

* Premium members only.

The historical data trend for Inmolecule Nanotech's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inmolecule Nanotech Research & Development Chart

Inmolecule Nanotech Annual Data
Trend Dec23 Dec24
Research & Development
0.00 0.00

Inmolecule Nanotech Semi-Annual Data
Dec23 Dec24
Research & Development 0.00 0.00
XPAR:MLINA
6GF Score
Inmolecule Nanotech SA XPAR:MLINA
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inmolecule Nanotech Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of € Mil mean?
Inmolecule Nanotech (XPAR:MLINA) has a Research & Development of € Mil as of Dec. 2024. Research and development expense is the total cost for research and development activities. View historical data on Inmolecule Nanotech and its competitors.
Is Inmolecule Nanotech's Research & Development too high?
Inmolecule Nanotech's current Research & Development is € Mil. Overall, Inmolecule Nanotech has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Inmolecule Nanotech's Research & Development compare to VRTX and REGN?
Inmolecule Nanotech's Research & Development of € Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Inmolecule Nanotech and its competitors. Inmolecule Nanotech's current Research & Development is € Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inmolecule Nanotech stock overvalued right now?
Inmolecule Nanotech (XPAR:MLINA) has a current Research & Development of € Mil. The current Research & Development is € Mil. Inmolecule Nanotech's overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Inmolecule Nanotech (XPAR:MLINA), the current Research & Development is € Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Inmolecule Nanotech Business Description

Address Paseo de la Castellana 91, 4th Floor, Madrid, ESP, 28046
Inmolecule Nanotech SA is a research and development company. The company provides health care, home care and personal care products.
6GF Score

Get the complete analysis for XPAR:MLINA

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.08
Price